Clinical characteristics in black and white men with prostate cancer in an equal access medical center

Stephen J. Freedland, Mark E Sutter, John Naitoh, Frederick Dorey, George S. Csathy, William J. Aronson

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objectives. To determine whether black men with newly diagnosed prostate cancer in an equal access health care center are more likely to present with metastatic disease, more poorly differentiated tumors, higher serum prostate-specific antigen (PSA) levels, and/or at younger ages compared with white men.Methods. A retrospective survey was conducted that identified black and white men with newly diagnosed prostate cancer at the Los Angeles Regional Veterans Affairs Clinics between 1991 and 1997. Patient data were analyzed for racial differences in age at diagnosis, clinical stage, PSA level, and Gleason score of the prostate biopsy specimens.Results. A total of 477 evaluable patients (230 black, 247 white) with newly diagnosed prostate cancer were identified. No significant differences in the average age (66.9 ± 7.3 versus 67.9 ± 7.5) or clinical stage at diagnosis were found between black and white men. Among black men, 87% presented with clinically localized disease (T1-2, Nx, M0) compared with 88% of white men. Only 6% of black men presented with distant disease (Tx, Nx, M1) compared with 4% of white men. Black men had higher median PSA levels than white men (14.2 versus 9.4 ng/mL, P = 0.0001). Black men also had slightly higher average Gleason scores (6.2 versus 5.9, P = 0.025).Conclusions. This is the first study to show a low and equal percentage of black and white men presenting with metastatic prostate cancer. In this equal access center, no differences were found in patient age or clinical stage of prostate cancer between black and white men at the time of diagnosis. However, black men presented with higher serum PSA values and slightly higher Gleason scores. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)387-390
Number of pages4
JournalUrology
Volume55
Issue number3
DOIs
StatePublished - Mar 2000

Fingerprint

Prostatic Neoplasms
Prostate-Specific Antigen
Neoplasm Grading
hydroquinone
Los Angeles
Veterans
Serum
Prostate
Delivery of Health Care
Biopsy

ASJC Scopus subject areas

  • Urology

Cite this

Freedland, S. J., Sutter, M. E., Naitoh, J., Dorey, F., Csathy, G. S., & Aronson, W. J. (2000). Clinical characteristics in black and white men with prostate cancer in an equal access medical center. Urology, 55(3), 387-390. https://doi.org/10.1016/S0090-4295(99)00461-6

Clinical characteristics in black and white men with prostate cancer in an equal access medical center. / Freedland, Stephen J.; Sutter, Mark E; Naitoh, John; Dorey, Frederick; Csathy, George S.; Aronson, William J.

In: Urology, Vol. 55, No. 3, 03.2000, p. 387-390.

Research output: Contribution to journalArticle

Freedland, SJ, Sutter, ME, Naitoh, J, Dorey, F, Csathy, GS & Aronson, WJ 2000, 'Clinical characteristics in black and white men with prostate cancer in an equal access medical center', Urology, vol. 55, no. 3, pp. 387-390. https://doi.org/10.1016/S0090-4295(99)00461-6
Freedland, Stephen J. ; Sutter, Mark E ; Naitoh, John ; Dorey, Frederick ; Csathy, George S. ; Aronson, William J. / Clinical characteristics in black and white men with prostate cancer in an equal access medical center. In: Urology. 2000 ; Vol. 55, No. 3. pp. 387-390.
@article{5dab6d4a820948aa98641e18397f243f,
title = "Clinical characteristics in black and white men with prostate cancer in an equal access medical center",
abstract = "Objectives. To determine whether black men with newly diagnosed prostate cancer in an equal access health care center are more likely to present with metastatic disease, more poorly differentiated tumors, higher serum prostate-specific antigen (PSA) levels, and/or at younger ages compared with white men.Methods. A retrospective survey was conducted that identified black and white men with newly diagnosed prostate cancer at the Los Angeles Regional Veterans Affairs Clinics between 1991 and 1997. Patient data were analyzed for racial differences in age at diagnosis, clinical stage, PSA level, and Gleason score of the prostate biopsy specimens.Results. A total of 477 evaluable patients (230 black, 247 white) with newly diagnosed prostate cancer were identified. No significant differences in the average age (66.9 ± 7.3 versus 67.9 ± 7.5) or clinical stage at diagnosis were found between black and white men. Among black men, 87{\%} presented with clinically localized disease (T1-2, Nx, M0) compared with 88{\%} of white men. Only 6{\%} of black men presented with distant disease (Tx, Nx, M1) compared with 4{\%} of white men. Black men had higher median PSA levels than white men (14.2 versus 9.4 ng/mL, P = 0.0001). Black men also had slightly higher average Gleason scores (6.2 versus 5.9, P = 0.025).Conclusions. This is the first study to show a low and equal percentage of black and white men presenting with metastatic prostate cancer. In this equal access center, no differences were found in patient age or clinical stage of prostate cancer between black and white men at the time of diagnosis. However, black men presented with higher serum PSA values and slightly higher Gleason scores. Copyright (C) 2000 Elsevier Science Inc.",
author = "Freedland, {Stephen J.} and Sutter, {Mark E} and John Naitoh and Frederick Dorey and Csathy, {George S.} and Aronson, {William J.}",
year = "2000",
month = "3",
doi = "10.1016/S0090-4295(99)00461-6",
language = "English (US)",
volume = "55",
pages = "387--390",
journal = "Urology",
issn = "1527-9995",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical characteristics in black and white men with prostate cancer in an equal access medical center

AU - Freedland, Stephen J.

AU - Sutter, Mark E

AU - Naitoh, John

AU - Dorey, Frederick

AU - Csathy, George S.

AU - Aronson, William J.

PY - 2000/3

Y1 - 2000/3

N2 - Objectives. To determine whether black men with newly diagnosed prostate cancer in an equal access health care center are more likely to present with metastatic disease, more poorly differentiated tumors, higher serum prostate-specific antigen (PSA) levels, and/or at younger ages compared with white men.Methods. A retrospective survey was conducted that identified black and white men with newly diagnosed prostate cancer at the Los Angeles Regional Veterans Affairs Clinics between 1991 and 1997. Patient data were analyzed for racial differences in age at diagnosis, clinical stage, PSA level, and Gleason score of the prostate biopsy specimens.Results. A total of 477 evaluable patients (230 black, 247 white) with newly diagnosed prostate cancer were identified. No significant differences in the average age (66.9 ± 7.3 versus 67.9 ± 7.5) or clinical stage at diagnosis were found between black and white men. Among black men, 87% presented with clinically localized disease (T1-2, Nx, M0) compared with 88% of white men. Only 6% of black men presented with distant disease (Tx, Nx, M1) compared with 4% of white men. Black men had higher median PSA levels than white men (14.2 versus 9.4 ng/mL, P = 0.0001). Black men also had slightly higher average Gleason scores (6.2 versus 5.9, P = 0.025).Conclusions. This is the first study to show a low and equal percentage of black and white men presenting with metastatic prostate cancer. In this equal access center, no differences were found in patient age or clinical stage of prostate cancer between black and white men at the time of diagnosis. However, black men presented with higher serum PSA values and slightly higher Gleason scores. Copyright (C) 2000 Elsevier Science Inc.

AB - Objectives. To determine whether black men with newly diagnosed prostate cancer in an equal access health care center are more likely to present with metastatic disease, more poorly differentiated tumors, higher serum prostate-specific antigen (PSA) levels, and/or at younger ages compared with white men.Methods. A retrospective survey was conducted that identified black and white men with newly diagnosed prostate cancer at the Los Angeles Regional Veterans Affairs Clinics between 1991 and 1997. Patient data were analyzed for racial differences in age at diagnosis, clinical stage, PSA level, and Gleason score of the prostate biopsy specimens.Results. A total of 477 evaluable patients (230 black, 247 white) with newly diagnosed prostate cancer were identified. No significant differences in the average age (66.9 ± 7.3 versus 67.9 ± 7.5) or clinical stage at diagnosis were found between black and white men. Among black men, 87% presented with clinically localized disease (T1-2, Nx, M0) compared with 88% of white men. Only 6% of black men presented with distant disease (Tx, Nx, M1) compared with 4% of white men. Black men had higher median PSA levels than white men (14.2 versus 9.4 ng/mL, P = 0.0001). Black men also had slightly higher average Gleason scores (6.2 versus 5.9, P = 0.025).Conclusions. This is the first study to show a low and equal percentage of black and white men presenting with metastatic prostate cancer. In this equal access center, no differences were found in patient age or clinical stage of prostate cancer between black and white men at the time of diagnosis. However, black men presented with higher serum PSA values and slightly higher Gleason scores. Copyright (C) 2000 Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033968966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033968966&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(99)00461-6

DO - 10.1016/S0090-4295(99)00461-6

M3 - Article

C2 - 10699616

AN - SCOPUS:0033968966

VL - 55

SP - 387

EP - 390

JO - Urology

JF - Urology

SN - 1527-9995

IS - 3

ER -